Temasek-backed Heliconia acquires 2% stake in HMI through S$11m placement
Nisha Ramchandani
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
TEMASEK-owned Heliconia Capital Management is acquiring a 2 per cent stake in Health Management International (HMI) through an S$11 million placement, which will help fuel the private healthcare player's expansion efforts.
HMI will issue 16.9 million new ordinary shares at S$0.65 per share to Orchid 2 Investments, a company managed and controlled by Heliconia. The issue price represents a discount of 0.76 per cent to the counter's closing price of S$0.655 on Nov 13 and a premium of 0.9 per cent to the volume-weighted average closing price of HMI shares traded on the Singapore Exchange for the 30-day period ending Nov 13.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025